Extension of Time to File SOU

BATCH 360

GLOBAL LIFE SCIENCES SOLUTIONS USA LLC

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88007866
LAW OFFICE ASSIGNED LAW OFFICE 101
MARK SECTION
MARK BATCH 360 (see, http://uspto.report/TM/88007866/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BATCH 360
OWNER SECTION (current)
NAME GE Healthcare Bio-Sciences Corp.
MAILING ADDRESS 100 Results Way
CITY Marlborough
STATE Massachusetts
ZIP/POSTAL CODE 01752
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME GE Healthcare Bio-Sciences Corp.
MAILING ADDRESS 100 Results Way
CITY Marlborough
STATE Massachusetts
ZIP/POSTAL CODE 01752
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Dyan M. House
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE dallastrademarks@bakermckenzie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) GIPSCOfficeSupport@bakermckenzie.com; gipsc@bakermckenzie.com
CORRESPONDENCE INFORMATION (proposed)
NAME Dyan M. House
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE dallastrademarks@bakermckenzie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) GIPSCOfficeSupport@bakermckenzie.com; gipsc@bakermckenzie.com; IPTrademarks@cytiva.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION providing an online portal featuring information on bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals; scientific consulting services in the life sciences field; consulting services in relation to use of bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals; customization of bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 07/16/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Karen Hays/
SIGNATORY'S NAME Karen Hays
SIGNATORY'S POSITION Associate Attorney, Baker & McKenzie LLP, New York Bar member
DATE SIGNED 07/13/2020
FILING INFORMATION
SUBMIT DATE Mon Jul 13 11:14:22 ET 2020
TEAS STAMP USPTO/ESU-XXX.XXX.XXX.XXX
-20200713111422922627-880
07866-74030cc3132fcfe806b
5731ac8a44a47b29a70826ebe
9d8bf81888cc4bb108d62-DA-
14224495-2020071311090859
4030



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: BATCH 360 (see, http://uspto.report/TM/88007866/mark.png)
SERIAL NUMBER: 88007866

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: GE Healthcare Bio-Sciences Corp., having an address of
      100 Results Way
      Marlborough, Massachusetts 01752
      United States
      Email: XXXX
Proposed: GE Healthcare Bio-Sciences Corp., having an address of
      100 Results Way
      Marlborough, Massachusetts 01752
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 07/16/2019.

For International Class 042:
Current identification: providing an online portal featuring information on bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals; scientific consulting services in the life sciences field; consulting services in relation to use of bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals; customization of bioprocessing and biomanufacturing software platforms for the production of biopharmaceuticals

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Dyan M. House
      PRIMARY EMAIL FOR CORRESPONDENCE: dallastrademarks@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): GIPSCOfficeSupport@bakermckenzie.com; gipsc@bakermckenzie.com

Correspondence Information (proposed):
      Dyan M. House
      PRIMARY EMAIL FOR CORRESPONDENCE: dallastrademarks@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): GIPSCOfficeSupport@bakermckenzie.com; gipsc@bakermckenzie.com; IPTrademarks@cytiva.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Karen Hays/      Date Signed: 07/13/2020
Signatory's Name: Karen Hays
Signatory's Position: Associate Attorney, Baker & McKenzie LLP, New York Bar member

RAM Sale Number: 88007866
RAM Accounting Date: 07/13/2020

Serial Number: 88007866
Internet Transmission Date: Mon Jul 13 11:14:22 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20200713111422
922627-88007866-74030cc3132fcfe806b5731a
c8a44a47b29a70826ebe9d8bf81888cc4bb108d6
2-DA-14224495-20200713110908594030




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed